Impact of body mass index on pulmonary complications in patients with non-Hodgkin lymphoma treated with hematopoietic stem cell transplant

References

• Breuer R, Lossos IS, Berkman N, et al. Pulmonary complications of bone marrow transplantation. Respir Med 1993;87:571–579.
   PubMed Web of Science ®Google Scholar
• Quabeck K. The lung as a critical organ in marrow transplantation. Bone Marrow Transplant 1994;14(Suppl. 4):S19–S28.
   PubMed Web of Science ®Google Scholar
• Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest 1996;109:1066–1077.
   PubMed Web of Science ®Google Scholar
• Krowka MJ, Staats BA, Hoagland HC. A prospective study of airway reactivity before bone marrow transplantation. Mayo Clin Proc 1990;65:5–12.
   PubMed Web of Science ®Google Scholar
• Santo Tomas LH, Loberiza FR Jr, Klein JP, et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 2005;128:153–161.
   PubMed Web of Science ®Google Scholar
• Izawa H, Hirowatari H, Yahata Y, et al. Effect of dose fractionation on pulmonary complications during total body irradiation. J Radiat Res 2011;52:502–508.
   PubMed Web of Science ®Google Scholar
• Patriarca F, Poletti V, Costabel U, et al. Clinical presentation, outcome and risk factors of late-onset non-infectious pulmonary complications after allogeneic stem cell transplantation. Curr Stem Cell Res Ther 2009;4:161–167.
   PubMed Web of Science ®Google Scholar
• Navarro WH, Loberiza FR Jr, Bajorunaite R, et al. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006;12:541–551.
   PubMed Web of Science ®Google Scholar
• Crowther M, Avenell A, Culligan DJ. Being underweight may reduce your ability to mobilise peripheral blood stem cells. Transfus Apher Sci 2010;43:365–367.
   PubMed Web of Science ®Google Scholar
• Fuji S, Takano K, Mori T, et al. Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT. Bone Marrow Transplant 2014;49:1505–1512.
   PubMed Web of Science ®Google Scholar
• Jaime-Perez JC, Colunga-Pedraza PR, Gutierrez-Gurrola B, et al. Obesity is associated with higher overall survival in patients undergoing an outpatient reduced-intensity conditioning hematopoietic stem cell transplant. Blood Cells Mol Dis 2013;51:61–65.
   PubMed Web of Science ®Google Scholar
• Navarro WH, Agovi MA, Logan BR, et al. Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. Biol Blood Marrow Transplant 2010;16:1442–1450.
   PubMed Web of Science ®Google Scholar
• White M, Murphy AJ, Hallahan A, et al. Survival in overweight and underweight children undergoing hematopoietic stem cell transplantation. Eur J Clin Nutr 2012;66:1120–1123.
   PubMed Web of Science ®Google Scholar
• Meloni G, Proia A, Capria S, et al. Obesity and autologous stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplant 2001;28:365–367.
   PubMed Web of Science ®Google Scholar
• Barker CC, Agovi MA, Logan B, et al. Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. Biol Blood Marrow Transplant 2011;17:737–744.
   PubMed Web of Science ®Google Scholar
• Bulley S, Gassas A, Dupuis LL, et al. Inferior outcomes for overweight children undergoing allogeneic stem cell transplantation. Br J Haematol 2008;140:214–217.
   PubMed Web of Science ®Google Scholar
• Tarella C, Caracciolo D, Gavarotti P, et al. Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft. Bone Marrow Transplant 2000;26:1185–1191.
   PubMed Web of Science ®Google Scholar
• Fuji S, Kim SW, Yoshimura K, et al. Possible association between obesity and posttransplantation complications including infectious diseases and acute graft-versus-host disease. Biol Blood Marrow Transplant 2009;15:73–82.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Ringden O, Remberger M. A low body mass index is correlated with poor survival after allogeneic stem cell transplantation. Haematologica 2003;88:1044–1052.
   PubMed Web of Science ®Google Scholar
• Auner HW, Zebisch A, Ofner P, et al. Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseases. Ann Hematol 2005;84:532–537.
   PubMed Web of Science ®Google Scholar
• Majhail NS, Parks K, Defor TE, et al. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes. Biol Blood Marrow Transplant 2006;12:1038–1046.
   PubMed Web of Science ®Google Scholar
• Weiner RS, Bortin MM, Gale RP, et al. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med 1986;104:168–175.
   PubMed Web of Science ®Google Scholar
• Fukuda T, Hackman RC, Guthrie KA, et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 2003;102:2777–2785.
   PubMed Web of Science ®Google Scholar
• Gopal R, Ha CS, Tucker SL, et al. Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity. Cancer 2001;92:1949–1958.
   PubMed Web of Science ®Google Scholar
• Chen CI, Abraham R, Tsang R, et al. Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes. Bone Marrow Transplant 2001;27:177–182.
   PubMed Web of Science ®Google Scholar
• Thomas O, Mahe M, Campion L, et al. Long-term complications of total body irradiation in adults. Int J Radiat Oncol Biol Phys 2001;49:125–131.
   PubMed Web of Science ®Google Scholar
• Carlson K, Backlund L, Smedmyr B, et al. Pulmonary function and complications subsequent to autologous bone marrow transplantation. Bone Marrow Transplant 1994;14:805–811.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee MH, Kim WS, et al. Tuberculosis in hematopoietic stem cell transplant recipients in Korea. Int J Hematol 2004;79: 185–188.
   PubMed Web of Science ®Google Scholar
• Diaconescu R, Flowers CR, Storer B, et al. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood 2004;104:1550–1558.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Delgado F, Holmberg L, Hooper H, et al. Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen. Bone Marrow Transplant 2003;32:279–285.
   PubMed Web of Science ®Google Scholar
• Ringden O, Remberger M, Ruutu T, et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group. Blood 1999;93:2196–2201.
   Google Scholar
• Aguilar-Guisado M, Jimenez-Jambrina M, Espigado I, et al. Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study. Clin Transplant 2011;25:E629–E638.
   PubMed Web of Science ®Google Scholar